Showing results (1-10 of 1) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Immunology|August 7, 2020
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancerM P Petrova, I S Donev, M A Radanova, et al.
Pageof 1